[go: up one dir, main page]

AU2003256209A1 - Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents - Google Patents

Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents

Info

Publication number
AU2003256209A1
AU2003256209A1 AU2003256209A AU2003256209A AU2003256209A1 AU 2003256209 A1 AU2003256209 A1 AU 2003256209A1 AU 2003256209 A AU2003256209 A AU 2003256209A AU 2003256209 A AU2003256209 A AU 2003256209A AU 2003256209 A1 AU2003256209 A1 AU 2003256209A1
Authority
AU
Australia
Prior art keywords
eta
identification
methods
protein kinase
human protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003256209A
Inventor
Anneli Attersand
Staffan Lake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum AB filed Critical Biovitrum AB
Publication of AU2003256209A1 publication Critical patent/AU2003256209A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2003256209A 2002-09-04 2003-09-03 Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents Abandoned AU2003256209A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0202608-6 2002-09-04
SE0202608A SE0202608D0 (en) 2002-09-04 2002-09-04 New sequences
PCT/SE2003/001361 WO2004022592A1 (en) 2002-09-04 2003-09-03 Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents

Publications (1)

Publication Number Publication Date
AU2003256209A1 true AU2003256209A1 (en) 2004-03-29

Family

ID=20288884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003256209A Abandoned AU2003256209A1 (en) 2002-09-04 2003-09-03 Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents

Country Status (3)

Country Link
AU (1) AU2003256209A1 (en)
SE (1) SE0202608D0 (en)
WO (1) WO2004022592A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007089546A (en) * 2005-09-30 2007-04-12 Univ Of Tokushima Rheumatoid arthritis susceptibility gene and method for measuring the risk of developing rheumatoid arthritis
JPWO2007123233A1 (en) 2006-04-25 2009-09-10 国立大学法人九州大学 Atherosclerotic disease-related genes and uses thereof
CN110520144B (en) * 2017-02-19 2024-04-05 本-古里安大学B.G.内盖夫技术和应用公司 Peptide kinase inhibitors and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055664A2 (en) * 2001-01-12 2002-07-18 Exelixis, Inc. Modulating insulin receptor signaling

Also Published As

Publication number Publication date
SE0202608D0 (en) 2002-09-04
WO2004022592A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
EP1501514A4 (en) Protein kinase modulators and methods of use
PL375447A1 (en) Protein kinase inhibitors and uses thereof
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
AU2003283786A1 (en) Surgical tools and techniques for stimulation
EP1511730B8 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
AU2003272601B2 (en) Sustained-release opioid formulations and methods of use
AU2003261251A1 (en) Methods of delivering therapeutic agents
IL176737A0 (en) Pyrazolo[1,5-a] pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
AU2001270260A1 (en) 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003216592A8 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
AU2003223579A1 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2003298937A1 (en) Heterocyclic compounds, methods of making them and their use in therapy
AU2002317105A1 (en) Methods for identifying therapeutic agents for treating diseases involving wnt polypeptides and wnt receptors
AU2003289742A1 (en) Stable therapeutic proteins
AU2001292019A1 (en) Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
AU2002352007A1 (en) Agents and methods for detecting human adenoviruses
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2004229218B2 (en) Thorium-227 for use in radiotherapy of soft tissue disease
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2003256209A1 (en) Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003284597A1 (en) Apoptosis-associated protein and use thereof
AU2002351798A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase